Accelerate Diagnostics Stock Analysis
Technical stock analysis for 23 January 2019
Accelerate Diagnostics fell by -1.72% in the last day from $16.85 to $16.56 The price has risen in 8 of the last 10 days and is up by 14.52% over the past 2 weeks. Volume has increased in the last day by 161 461 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 738 267 shares bought and sold for approximately $12.23 million.
Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the AXDX stock was $16.56. This is 1.72% less than the trading day before Tuesday, 22nd Jan 2019.
During day the stock fluctuated 7.46% from a day low at $16.23 to a day high of $17.44.
30 day high of the AXDX stock price was $17.44 and low was $10.25.
90 day high was $17.44 and low was $10.23.
52 week high for the Accelerate Diagnostics - $30.35 and low - $10.23.
Accelerate Diagnostics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $16.84 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -4.09% during the next 3 months and, with 90% probability hold a price between $9.76 and $16.15 at the end of this period.
Accelerate Diagnostics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $16.22 and $13.66. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday January 22, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
The stock holds a RSI14 at 83 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $14.97 and $14.62.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Accelerate Diagnostics finds support just below today's level at $14.97. If this is broken, then the next support from accumulated volume will be at $14.62 and $14.42.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.21 between high and low, or 7.46%. For the last week, the stock has had a daily average volatility of 4.78%.
The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stoploss: $15.74 (-4.94%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 83 and this increases the risk substantially. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Accelerate Diagnostics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.
|AXDX $16.56 $-0.29(-1.72%)|
AXDX is down $0.29 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AXDX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the AXDX analysis is free »